Matthieu Allez is Head of the Department of Gastroenterology and Hepatology at Saint-Louis Hospital in Paris, France. After he gained his medical degree, Professor Allez spent 2 years as a visiting associate in the Department of Immunobiology at Mount Sinai Medical Center in New York City, NY, USA, and was appointed Professor of Gastroenterology at the Paris Diderot University, Paris, in 2006.
Professor Allez is specialized in inflammatory bowel diseases (IBD). His main research interests focus on regulation of mucosal immune responses, identification of biomarkers, and biological therapies for IBD. He has authored or co-authored more than 170 publications in peer-reviewed journals, including Gastroenterology, Gut, American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology, Journal of Crohn’s and Colitis, Mucosal Immunology and JAMA.
Professor Allez served the European Crohn’s and Colitis Organisation (ECCO) as Chair of the Scientific Committee and Scientific Officer, and as member of the Scientific Committee of United European Gastroenterology (UEG). He is a member of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD), a member of the Groupe d'Étude Thérapeutique des Affections Inflammatoires Digestives (GETAID), co-founder and President of the French research group REMIND, and Vice-President of the AFEMI (a national organization for therapeutic education in IBD).
EM-25597 - Date of preparation: January 2020